Skip to main navigation
Header Menu
Logo
  • About
    • Overview
    • Management
    • Board of Directors
  • Products
    • SYMJEPI® (epinephrine)
    • ZIMHI™ (naloxone)
  • Pipeline
    • Specialty Pharmaceuticals
    • APC-400 (tempol) – Capsule
  • Patients
  • Investors & Media
    • Overview
    • News Releases
    • Stock Information
    • SEC Filings
    • Events & Presentations
    • Email Alerts
    • Governance
  • Careers
    • Careers
    • Partnerships
  • Contact Us

SEC Filing Details

Document Details

Form
8-K
Filing Date
Dec 30, 2022
Document Date
Dec 28, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Adamis Pharmaceuticals Corporation
Issuer
ADAMIS PHARMACEUTICALS CORP

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

Sign Up For Adamis Email Alerts

Choose Your Preferences
Adamis Pharmaceuticals Corporation logo

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease.

02. Footer - Social Links
  • LinkedIn
  • Twitter
Footer - Column 2
COMPANY
  • About Us
  • Overview
  • Management
  • Board of Directors
Products
  • SYMJEPI® (epinephrine)
  • ZIMHI® (naloxone)
Pipeline
  • Specialty Pharmaceuticals
  • APC-400 (tempol) – Capsule
Footer - Column 3 (Hidden on Desktop)
Investors & Media
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events & Presentations
  • Email Alerts
  • Corporate Governance
Connect
  • Careers
  • Partnerships
  • Contact Us
Footer - Column 4
Products
  • SYMJEPI® (epinephrine)
  • ZIMHI® (naloxone)
Pipeline
  • Specialty Pharmaceuticals
  • APC-400 (tempol) – Capsule
Footer - Column 5
Investors & Media
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events & Presentations
  • Email Alerts
  • Corporate Governance
Footer - Column 6
Connect
  • Careers
  • Partnerships
  • Contact Us

© 2023 Copyright Adamis Pharmaceuticals Corporation

Footer Copyright Links
  • Terms and Conditions
  • Privacy Policy